Viral Infection clinical trials
15 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- Adoptive Cord Blood Immunotherapy for EBV, CMV, BKV and Adenovirus Reactivation/Infection or Prophylaxis
- Adoptive T Lymphocyte Administration for Chronic Norovirus Treatment in Immunocompromised Hosts
- Third Party Viral Specific T-cells (VSTs)
- Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
- TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT.
- Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions
- Donor-Derived Viral Specific T-cells (VSTs)
- School Inner City Air Study
- The Natural History of Severe Viral Infections and Characterization of Immune Defects in Patients Without Known Immunocompromise
- Viral Infections in Healthy and Immunocompromised Hosts
- Trial of Scheduled Versus Treatment Administration of Donor-Derived Viral Specific T-cells for Viral Infections After Stem Cell Transplant
- Effects of Mouthrinse on the Microbiome of the Oral Cavity and GI Tract
- Reducing Overuse of Antibiotics With Decision Support
- Personalized Ventilator Settings for Patients on ECMO
- Analysis of the Virtual Acute Care at Home Experience
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Viral Infection” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.